Free Trial
NYSE:MTNB

Matinas Biopharma (MTNB) Stock Price, News & Analysis

Matinas Biopharma logo
$0.96 0.00 (0.00%)
Closing price 03:59 PM Eastern
Extended Trading
$0.98 +0.02 (+2.08%)
As of 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Matinas Biopharma Stock (NYSE:MTNB)

Key Stats

Today's Range
$0.94
$1.03
50-Day Range
$0.63
$1.04
52-Week Range
$0.47
$9.35
Volume
45,664 shs
Average Volume
241,452 shs
Market Capitalization
$4.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Receive MTNB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter.

MTNB Stock News Headlines

MTNB Matinas BioPharma Holdings, Inc. - Seeking Alpha
Matinas BioPharma Holdings, Inc. (MTNB) - Yahoo Finance
This Could Be the Most Profitable Season of Your Life
Institutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the same point in every cycle when crypto enters its most explosive phase — and two experts are showing how to ride it. Inside The Crypto Code Workshop, you’ll get their step-by-step system and $10 in free Bitcoin for attending.
Matinas BioPharma files to sell 16.9M shares of common stock for holders
Matinas BioPharma appoints Murphy, Neugeboren to board of directors
See More Headlines

MTNB Stock Analysis - Frequently Asked Questions

Matinas Biopharma's stock was trading at $0.51 at the beginning of 2025. Since then, MTNB shares have increased by 88.2% and is now trading at $0.96.

Matinas Biopharma Holdings, Inc. (NYSE:MTNB) released its quarterly earnings results on Wednesday, August, 14th. The company reported ($0.02) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.02).

Shares of MTNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Matinas Biopharma investors own include AcelRx Pharmaceuticals (ACRX), DURECT (DRRX), Kosmos Energy (KOS), Strongbridge Biopharma (SBBP), Selecta Biosciences (SELB), Acasti Pharma (ACST) and Abeona Therapeutics (ABEO).

Company Calendar

Last Earnings
8/14/2024
Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:MTNB
Previous Symbol
NYSE:MTNB
CIK
1582554
Web
N/A
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.86)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$22.94 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-123.06%
Return on Assets
-94.28%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.53
Quick Ratio
5.53

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.43 per share
Price / Book
0.22

Miscellaneous

Outstanding Shares
5,087,000
Free Float
4,599,000
Market Cap
$5.06 million
Optionable
N/A
Beta
1.31
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NYSE:MTNB) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners